KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Other Operating Expenses: 2017-2020

Historic Other Operating Expenses for BeOne Medicines (ONC) over the last 4 years, with Dec 2020 value amounting to $71.5 million.

  • BeOne Medicines' Other Operating Expenses fell 99.74% to $188,000 in Q2 2023 from the same period last year, while for Jun 2023 it was -$136.4 million, marking a year-over-year decrease of 302.20%. This contributed to the annual value of $71.5 million for FY2020, which is 1.40% down from last year.
  • BeOne Medicines' Other Operating Expenses amounted to $71.5 million in FY2020, which was down 1.40% from $72.5 million recorded in FY2019.
  • BeOne Medicines' Other Operating Expenses' 5-year high stood at $72.5 million during FY2019, with a 5-year trough of $5.2 million in FY2017.
  • In the last 3 years, BeOne Medicines' Other Operating Expenses had a median value of $71.5 million in 2020 and averaged $57.9 million.
  • As far as peak fluctuations go, BeOne Medicines' Other Operating Expenses skyrocketed by 466.60% in 2018, and later declined by 1.40% in 2020.
  • Yearly analysis of 4 years shows BeOne Medicines' Other Operating Expenses stood at $5.2 million in 2017, then skyrocketed by 466.60% to $29.6 million in 2018, then surged by 144.99% to $72.5 million in 2019, then dropped by 1.40% to $71.5 million in 2020.